Cargando…
Can testing clinical significance reduce false positive rates in randomized controlled trials? A snap review
OBJECTIVE: The use of minimum clinically important difference in the hypothesis formulation for superiority trials is similar in principle to the concept of non-inferiority or equivalence trial. However, most clinical trials are analysed testing zero clinical difference. Since the minimum clinically...
Autores principales: | Bigirumurame, Theophile, Kasim, Adetayo S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745896/ https://www.ncbi.nlm.nih.gov/pubmed/29282120 http://dx.doi.org/10.1186/s13104-017-3117-4 |
Ejemplares similares
-
Controlling false positive rates in mass-multivariate tests for electromagnetic responses
por: Barnes, Gareth R., et al.
Publicado: (2011) -
Proposal for a new clinical test for diagnosing lateral hip snapping()()
por: de Amorim Cabrita, Henrique Antonio Berwanger, et al.
Publicado: (2014) -
Controlling false discovery rates in factorial experiments with between-subjects and within-subjects tests
por: Schoen, Eric D, et al.
Publicado: (2013) -
SNAP predicts effect of mutations on protein function
por: Bromberg, Yana, et al.
Publicado: (2008) -
A note on the false discovery rate of novel peptides in proteogenomics
por: Zhang, Kun, et al.
Publicado: (2015)